Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease. (Q48614100)
Jump to navigation
Jump to search
scientific article published on 8 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease. |
scientific article published on 8 August 2014 |
Statements
1 reference
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease. (English)
1 reference
1 reference
Paula L McClean
1 reference
8 August 2014
1 reference
1 reference
86
1 reference
241-258
1 reference
Identifiers
1 reference
1 reference